Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03525054

Semantic and Syntactic Computerized Analysis of Free Speech

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
15 Years – 30 Years
Healthy volunteers
Not accepted

Summary

Subtle speech disorganization could be predictive of a transition to schizophrenia of ultra-high-risk patients. The aim of our longitudinal multicenter cohort study is to identify specific linguistic markers of the psychotic transition to validate a french predictive model of this transition using computerized speech analysis techniques

Detailed description

Different scales allow identification of patients at ultra-high-risk to develop psychosis. The current challenge is to identify a predictive marker of transition to schizophrenia. Language disorders, which reflect psyche, could be one of these markers. Computerized speech analysis techniques such as Latent Semantic Analysis (LSA) have already proven their reliability in schizophrenia. These techniques reveal subtle speech disorganization that would be predictive of a clinical transition of ultra-high-risk psychotic patients. A combination of semantic and syntactic analysis could accurately predict the psychotic transition. The aim of our longitudinal multicenter cohort study is to validate this predicitve model in french language as well as identifying specific linguistic markers of the psychotic transition. The initial report including the CAARMS is completed with an audio recording from the initial medical interview. The recording will be transcribed and analyzed by computer following the method of lemmatization and vectorial analysis (LSA). An analysis of the grammatical function (number of words, rate of the various grammatical functions) will also be performed. This first analysis will emerge linguistic markers correlated to transition to psychosis that we will use to construct a predictive model for transition to schizophrenia.

Conditions

Timeline

Start date
2018-05-18
Primary completion
2028-05-02
Completion
2028-05-02
First posted
2018-05-15
Last updated
2024-09-26

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03525054. Inclusion in this directory is not an endorsement.